# Study of IFN-K in Dermatomyositis

> **NCT02980198** · PHASE2 · WITHDRAWN · sponsor: **Neovacs**

## Conditions studied

- Dermatomyositis

## Interventions

- **BIOLOGICAL:** IFN-Kinoid
- **OTHER:** Placebo
- **OTHER:** ISA 51

## Key facts

- **NCT ID:** NCT02980198
- **Lead sponsor:** Neovacs
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-05-03
- **Primary completion:** 2019-12-11
- **Final completion:** 2019-12-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** reorganization proceedings with a potential risk of company liquidation
- **Last updated:** 2020-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02980198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02980198, "Study of IFN-K in Dermatomyositis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02980198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*